0
2022
Cosmetic Surgery Market

Cosmetic Surgery Market

By Gender (Female, Male), By Age Group (13 to 29, 30 to 54, 55 and above), By Procedure (Breast augmentation, Eyelid surgery, Liposuction, Rhinoplasty, Others), By End User (Ambulatory surgical facility, Hospital and clinic, Office and cosmetic surgical center): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A16492
May 2022 | Pages: 270
Tables: 174
Charts: 63
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Cosmetic Surgery Market Statistics - 2031

The global cosmetic surgery market size was valued at $67.3 billion in 2021, and is projected to reach $201.0 billion by 2031, growing at a CAGR of 11.6% from 2022 to 2031. Cosmetic surgery is voluntary procedure which is perform to reshape their body, body contouring and improve the physical appearance of patients. Cosmetic procedure involves unique discipline of surgical and non-surgical techniques which aims to improve person’s appearance. Cosmetic surgical procedure includes different type of surgeries like breast augmentation, rhinoplasty (Nose reshaping), liposuction, facelift, eyelid surgery (blepharoplasty). Along with that there are some gender specific cosmetic surgeries, in female genital cosmetic surgery includes numerous procedures, including hymenoplasty, labia majora augmentation, vaginoplasty, labiaplasty and G-spot amplification and in male breast reduction (gynecomastia surgery). Cosmetic surgeries can perform when body reach the full adult size. Generally, in male, at the age of 15-16 cosmetic surgeries can perform and in female, at the age of 14-15 cosmetic surgeries can perform.

The COVID-19 outbreak is anticipated to have a negative impact on growth of the global cosmetic surgery market. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Implementation of lockdown, owing to the COVID-19 outbreak resulted in decline in number of patient visits for aesthetic procedures during the pandemic. Cosmetic surgery procedures are non-emergency procedures significantly hampered revenue of aesthetic companies. According to the European Journal of Plastic surgery, in June 2021, it was reported that the total number of surgeries decreased by 23.5% after the COVID-19 outbreak.

The growth of the global cosmetic surgery market share is majorly driven by increase in prevalence of cosmetic surgical procedure; rise in demand for aesthetic procedure; and rise in technological advancement in healthcare sector. According to American Society of Plastic Surgeon, in 2020, it was reported that around 352,555 rhinoplasty procedure are performed in U.S in 2020. It was analyzed that the rhinoplasty was the leading surgical procedure performed in the U.S in 2020.

Cosmetic Surgery Market, Cosmetic Surgery Market size, Cosmetic Surgery Market share, Cosmetic Surgery Market trends, Cosmetic Surgery Market growth, Cosmetic Surgery Market analysis, Cosmetic Surgery Market forecast, Cosmetic Surgery Market opportunity

Furthermore, increase in number of approval for cosmetic surgical products drives cosmetic surgery market growth. For instance, in January 2021, Johnson and Johnson, a medical device and pharmaceutical company, received approval from U.S. Food and Drug Administration (FDA) for new mentor memorygel boost breast implant for breast augmentation in women. In addition, increase in demand for aesthetic procedure is anticipated to contribute toward cosmetic surgery market growth. Moreover, the increase in number of young female population, an rise in awareness about the skin treatment, surge the demand for cosmetic surgical procedure, and propel the cosmetic surgery market size. According to American Society of Plastic Surgeon, in 2020, it was reported that around 2 million cosmetic surgical procedure are conducted in female population

Furthermore, technological development in the medical device industry to manufacture advanced cosmetic surgical products is expected to provide remunerative opportunities for expansion of the global cosmetic surgery market during the cosmetic surgery market forecast. Moreover, presence of key manufacturing companies to manufacture cosmetic surgery products and rise in expenditure on healthcare products propel growth of the market. Initiatives taken by government and private organizations to develop healthcare industry propel the growth of the market. However, the side effect associated with cosmetic surgery, and high cost of cosmetic surgical procedure is expected to restrict the market growth during the forecast period.

Global Cosmetic Surgery Market Segmentation

The cosmetic surgery market is segmented into procedure, gender, age group, provider, and region. By procedure, the market is categorized into breast augmentation, eyelid surgery, liposuction, rhinoplasty, and others.

On the basis of gender, it is divided into female, and male. Depending on age group, it is categorized into 13 to 29, 30 to 54, and 54 and above.Depending on provider, it is categorized into Ambulatory surgical facilities, Hospital & clinics, and office and cosmetic surgical center. 

Cosmetic Surgery Market

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, Columbia, and rest of LAMEA).

Segment review

By type, the female segment was the major contributor in 2021, and is expected to maintain its lead during the forecast period, owing to increase in demand for aesthetic procedures, and rapidly growing emphasis on personal aesthetics among females, and increase in number of female populations conducting cosmetic surgery.

Cosmetic Surgery Market

On the basis of age group, the 30-54 segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing increase in demand for liposuction, and rise in number of cosmetic procedures in population of age group 30 to 54.

Cosmetic Surgery Market

Depending on procedure, the breast augmentation segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing increase in number of breast augmentation procedures, and increase in number of approvals for cosmetic surgeries in breast implant. 

Cosmetic Surgery Market

On the basis of Provider, the hospital a clinic segment dominated the market in 2021, and this trend is expected to continue during the forecast period, owing increase in number of cosmetic surgeries, and rise in number of hospitals and clinics to conduct various surgical procedures.

North America garnered a major share in the cosmetic surgery market in 2021, and is expected to continue to dominate during the forecast period, owing rise in number of breast augmentation procedures, increase in number of approvals for cosmetic surgery products, presence of cosmetic surgery industry, and advancements in healthcare, medical devices, and aesthetic sector in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of liposuctions, rise in awareness among young population regarding aesthetics sector, growth in health care expenditures, and rise in adoption of aesthetic products.

The key players operating in the global cosmetic surgery market include AbbVie Inc., Bausch Health Companies Inc., Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma, Teoxane Laboratories.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cosmetic surgery market analysis from 2021 to 2031 to identify the prevailingcosmetic surgery market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cosmetic surgery market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cosmetic surgery market trends, key players, market segments, application areas, and market growth strategies.

Cosmetic Surgery Market Report Highlights

Aspects Details
By Gender
  • Female
  • Male
By Age Group
  • 13 to 29
  • 30 to 54
  • 55 and above
By Procedure
  • Breast augmentation
  • Eyelid surgery
  • Liposuction
  • Rhinoplasty
  • Others
By End User
  • Ambulatory surgical facility
  • Hospital and clinic
  • Office and cosmetic surgical center
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific  (India, Australia, Rest of Asia-Pacific, China, Japan)
  • LAMEA  (Brazil, Saudi Arabia, Colombia, Rest of LAMEA)
Key Market Players Sinclair Pharmaceuticals Limited, Sientra Inc, Teoxane Laboratories, Johnson and Johnson, Bausch Health Companies Inc., Galderma SA, Abbvie Inc, Merz Pharma GmbH and Co. KGaA, Candela Syneron, cynosure inc
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: COSMETIC SURGERY MARKET, BY PROCEDURE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Breast augmentation

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Eyelid surgery

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Liposuction

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Rhinoplasty

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

    • 4.6 Others

      • 4.6.1 Key market trends, growth factors and opportunities

      • 4.6.2 Market size and forecast, by region

      • 4.6.3 Market analysis by country

  • CHAPTER 5: COSMETIC SURGERY MARKET, BY GENDER

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Female

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Male

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

  • CHAPTER 6: COSMETIC SURGERY MARKET, BY AGE GROUP

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 13 to 29

      • 6.2.1 Key market trends, growth factors and opportunities

      • 6.2.2 Market size and forecast, by region

      • 6.2.3 Market analysis by country

    • 6.3 30 to 54

      • 6.3.1 Key market trends, growth factors and opportunities

      • 6.3.2 Market size and forecast, by region

      • 6.3.3 Market analysis by country

    • 6.4 55 and above

      • 6.4.1 Key market trends, growth factors and opportunities

      • 6.4.2 Market size and forecast, by region

      • 6.4.3 Market analysis by country

  • CHAPTER 7: COSMETIC SURGERY MARKET, BY END USER

    • 7.1 Overview

      • 7.1.1 Market size and forecast

    • 7.2 Ambulatory surgical facility

      • 7.2.1 Key market trends, growth factors and opportunities

      • 7.2.2 Market size and forecast, by region

      • 7.2.3 Market analysis by country

    • 7.3 Hospital and clinic

      • 7.3.1 Key market trends, growth factors and opportunities

      • 7.3.2 Market size and forecast, by region

      • 7.3.3 Market analysis by country

    • 7.4 Office and cosmetic surgical center

      • 7.4.1 Key market trends, growth factors and opportunities

      • 7.4.2 Market size and forecast, by region

      • 7.4.3 Market analysis by country

  • CHAPTER 8: COSMETIC SURGERY MARKET, BY REGION

    • 8.1 Overview

      • 8.1.1 Market size and forecast

    • 8.2 North America

      • 8.2.1 Key trends and opportunities

      • 8.2.2 North America Market size and forecast, by Procedure

      • 8.2.3 North America Market size and forecast, by Gender

      • 8.2.4 North America Market size and forecast, by Age Group

      • 8.2.5 North America Market size and forecast, by End User

      • 8.2.6 North America Market size and forecast, by country

        • 8.2.6.1 U.S.
          • 8.2.6.1.1 Market size and forecast, by Procedure
          • 8.2.6.1.2 Market size and forecast, by Gender
          • 8.2.6.1.3 Market size and forecast, by Age Group
          • 8.2.6.1.4 Market size and forecast, by End User
        • 8.2.6.2 Canada
          • 8.2.6.2.1 Market size and forecast, by Procedure
          • 8.2.6.2.2 Market size and forecast, by Gender
          • 8.2.6.2.3 Market size and forecast, by Age Group
          • 8.2.6.2.4 Market size and forecast, by End User
        • 8.2.6.3 Mexico
          • 8.2.6.3.1 Market size and forecast, by Procedure
          • 8.2.6.3.2 Market size and forecast, by Gender
          • 8.2.6.3.3 Market size and forecast, by Age Group
          • 8.2.6.3.4 Market size and forecast, by End User
    • 8.3 Europe

      • 8.3.1 Key trends and opportunities

      • 8.3.2 Europe Market size and forecast, by Procedure

      • 8.3.3 Europe Market size and forecast, by Gender

      • 8.3.4 Europe Market size and forecast, by Age Group

      • 8.3.5 Europe Market size and forecast, by End User

      • 8.3.6 Europe Market size and forecast, by country

        • 8.3.6.1 Germany
          • 8.3.6.1.1 Market size and forecast, by Procedure
          • 8.3.6.1.2 Market size and forecast, by Gender
          • 8.3.6.1.3 Market size and forecast, by Age Group
          • 8.3.6.1.4 Market size and forecast, by End User
        • 8.3.6.2 France
          • 8.3.6.2.1 Market size and forecast, by Procedure
          • 8.3.6.2.2 Market size and forecast, by Gender
          • 8.3.6.2.3 Market size and forecast, by Age Group
          • 8.3.6.2.4 Market size and forecast, by End User
        • 8.3.6.3 U.K.
          • 8.3.6.3.1 Market size and forecast, by Procedure
          • 8.3.6.3.2 Market size and forecast, by Gender
          • 8.3.6.3.3 Market size and forecast, by Age Group
          • 8.3.6.3.4 Market size and forecast, by End User
        • 8.3.6.4 Italy
          • 8.3.6.4.1 Market size and forecast, by Procedure
          • 8.3.6.4.2 Market size and forecast, by Gender
          • 8.3.6.4.3 Market size and forecast, by Age Group
          • 8.3.6.4.4 Market size and forecast, by End User
        • 8.3.6.5 Spain
          • 8.3.6.5.1 Market size and forecast, by Procedure
          • 8.3.6.5.2 Market size and forecast, by Gender
          • 8.3.6.5.3 Market size and forecast, by Age Group
          • 8.3.6.5.4 Market size and forecast, by End User
        • 8.3.6.6 Rest of Europe
          • 8.3.6.6.1 Market size and forecast, by Procedure
          • 8.3.6.6.2 Market size and forecast, by Gender
          • 8.3.6.6.3 Market size and forecast, by Age Group
          • 8.3.6.6.4 Market size and forecast, by End User
    • 8.4 Asia-Pacific

      • 8.4.1 Key trends and opportunities

      • 8.4.2 Asia-Pacific Market size and forecast, by Procedure

      • 8.4.3 Asia-Pacific Market size and forecast, by Gender

      • 8.4.4 Asia-Pacific Market size and forecast, by Age Group

      • 8.4.5 Asia-Pacific Market size and forecast, by End User

      • 8.4.6 Asia-Pacific Market size and forecast, by country

        • 8.4.6.1 China
          • 8.4.6.1.1 Market size and forecast, by Procedure
          • 8.4.6.1.2 Market size and forecast, by Gender
          • 8.4.6.1.3 Market size and forecast, by Age Group
          • 8.4.6.1.4 Market size and forecast, by End User
        • 8.4.6.2 Japan
          • 8.4.6.2.1 Market size and forecast, by Procedure
          • 8.4.6.2.2 Market size and forecast, by Gender
          • 8.4.6.2.3 Market size and forecast, by Age Group
          • 8.4.6.2.4 Market size and forecast, by End User
        • 8.4.6.3 India
          • 8.4.6.3.1 Market size and forecast, by Procedure
          • 8.4.6.3.2 Market size and forecast, by Gender
          • 8.4.6.3.3 Market size and forecast, by Age Group
          • 8.4.6.3.4 Market size and forecast, by End User
        • 8.4.6.4 Australia
          • 8.4.6.4.1 Market size and forecast, by Procedure
          • 8.4.6.4.2 Market size and forecast, by Gender
          • 8.4.6.4.3 Market size and forecast, by Age Group
          • 8.4.6.4.4 Market size and forecast, by End User
        • 8.4.6.5 Rest of Asia-Pacific
          • 8.4.6.5.1 Market size and forecast, by Procedure
          • 8.4.6.5.2 Market size and forecast, by Gender
          • 8.4.6.5.3 Market size and forecast, by Age Group
          • 8.4.6.5.4 Market size and forecast, by End User
    • 8.5 LAMEA

      • 8.5.1 Key trends and opportunities

      • 8.5.2 LAMEA Market size and forecast, by Procedure

      • 8.5.3 LAMEA Market size and forecast, by Gender

      • 8.5.4 LAMEA Market size and forecast, by Age Group

      • 8.5.5 LAMEA Market size and forecast, by End User

      • 8.5.6 LAMEA Market size and forecast, by country

        • 8.5.6.1 Brazil
          • 8.5.6.1.1 Market size and forecast, by Procedure
          • 8.5.6.1.2 Market size and forecast, by Gender
          • 8.5.6.1.3 Market size and forecast, by Age Group
          • 8.5.6.1.4 Market size and forecast, by End User
        • 8.5.6.2 Saudi Arabia
          • 8.5.6.2.1 Market size and forecast, by Procedure
          • 8.5.6.2.2 Market size and forecast, by Gender
          • 8.5.6.2.3 Market size and forecast, by Age Group
          • 8.5.6.2.4 Market size and forecast, by End User
        • 8.5.6.3 Colombia
          • 8.5.6.3.1 Market size and forecast, by Procedure
          • 8.5.6.3.2 Market size and forecast, by Gender
          • 8.5.6.3.3 Market size and forecast, by Age Group
          • 8.5.6.3.4 Market size and forecast, by End User
        • 8.5.6.4 Rest of LAMEA
          • 8.5.6.4.1 Market size and forecast, by Procedure
          • 8.5.6.4.2 Market size and forecast, by Gender
          • 8.5.6.4.3 Market size and forecast, by Age Group
          • 8.5.6.4.4 Market size and forecast, by End User
  • CHAPTER 9: COMPANY LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top winning strategies

    • 9.3. Product Mapping of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Key developments

  • CHAPTER 10: COMPANY PROFILES

    • 10.1 Abbvie Inc

      • 10.1.1 Company overview

      • 10.1.2 Company snapshot

      • 10.1.3 Operating business segments

      • 10.1.4 Product portfolio

      • 10.1.5 Business performance

      • 10.1.6 Key strategic moves and developments

    • 10.2 Bausch Health Companies Inc.

      • 10.2.1 Company overview

      • 10.2.2 Company snapshot

      • 10.2.3 Operating business segments

      • 10.2.4 Product portfolio

      • 10.2.5 Business performance

      • 10.2.6 Key strategic moves and developments

    • 10.3 Candela Syneron

      • 10.3.1 Company overview

      • 10.3.2 Company snapshot

      • 10.3.3 Operating business segments

      • 10.3.4 Product portfolio

      • 10.3.5 Business performance

      • 10.3.6 Key strategic moves and developments

    • 10.4 cynosure inc

      • 10.4.1 Company overview

      • 10.4.2 Company snapshot

      • 10.4.3 Operating business segments

      • 10.4.4 Product portfolio

      • 10.4.5 Business performance

      • 10.4.6 Key strategic moves and developments

    • 10.5 Galderma SA

      • 10.5.1 Company overview

      • 10.5.2 Company snapshot

      • 10.5.3 Operating business segments

      • 10.5.4 Product portfolio

      • 10.5.5 Business performance

      • 10.5.6 Key strategic moves and developments

    • 10.6 Merz Pharma GmbH and Co. KGaA

      • 10.6.1 Company overview

      • 10.6.2 Company snapshot

      • 10.6.3 Operating business segments

      • 10.6.4 Product portfolio

      • 10.6.5 Business performance

      • 10.6.6 Key strategic moves and developments

    • 10.7 Sientra Inc

      • 10.7.1 Company overview

      • 10.7.2 Company snapshot

      • 10.7.3 Operating business segments

      • 10.7.4 Product portfolio

      • 10.7.5 Business performance

      • 10.7.6 Key strategic moves and developments

    • 10.8 Sinclair Pharmaceuticals Limited

      • 10.8.1 Company overview

      • 10.8.2 Company snapshot

      • 10.8.3 Operating business segments

      • 10.8.4 Product portfolio

      • 10.8.5 Business performance

      • 10.8.6 Key strategic moves and developments

    • 10.9 Teoxane Laboratories

      • 10.9.1 Company overview

      • 10.9.2 Company snapshot

      • 10.9.3 Operating business segments

      • 10.9.4 Product portfolio

      • 10.9.5 Business performance

      • 10.9.6 Key strategic moves and developments

    • 10.10 Johnson and Johnson

      • 10.10.1 Company overview

      • 10.10.2 Company snapshot

      • 10.10.3 Operating business segments

      • 10.10.4 Product portfolio

      • 10.10.5 Business performance

      • 10.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 2. COSMETIC SURGERY MARKET REVENUE, FOR BREAST AUGMENTATION, BY REGION , 2021-2031,($MILLION)
    TABLE 3. COSMETIC SURGERY MARKET FOR BREAST AUGMENTATION BY COUNTRY, 2021-2031,($MILLION)
    TABLE 4. COSMETIC SURGERY MARKET REVENUE, FOR EYELID SURGERY, BY REGION , 2021-2031,($MILLION)
    TABLE 5. COSMETIC SURGERY MARKET FOR EYELID SURGERY BY COUNTRY, 2021-2031,($MILLION)
    TABLE 6. COSMETIC SURGERY MARKET REVENUE, FOR LIPOSUCTION, BY REGION , 2021-2031,($MILLION)
    TABLE 7. COSMETIC SURGERY MARKET FOR LIPOSUCTION BY COUNTRY, 2021-2031,($MILLION)
    TABLE 8. COSMETIC SURGERY MARKET REVENUE, FOR RHINOPLASTY, BY REGION , 2021-2031,($MILLION)
    TABLE 9. COSMETIC SURGERY MARKET FOR RHINOPLASTY BY COUNTRY, 2021-2031,($MILLION)
    TABLE 10. COSMETIC SURGERY MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
    TABLE 11. COSMETIC SURGERY MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
    TABLE 12. GLOBAL COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 13. COSMETIC SURGERY MARKET REVENUE, FOR FEMALE, BY REGION , 2021-2031,($MILLION)
    TABLE 14. COSMETIC SURGERY MARKET FOR FEMALE BY COUNTRY, 2021-2031,($MILLION)
    TABLE 15. COSMETIC SURGERY MARKET REVENUE, FOR MALE, BY REGION , 2021-2031,($MILLION)
    TABLE 16. COSMETIC SURGERY MARKET FOR MALE BY COUNTRY, 2021-2031,($MILLION)
    TABLE 17. GLOBAL COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 18. COSMETIC SURGERY MARKET REVENUE, FOR 13 TO 29, BY REGION , 2021-2031,($MILLION)
    TABLE 19. COSMETIC SURGERY MARKET FOR 13 TO 29 BY COUNTRY, 2021-2031,($MILLION)
    TABLE 20. COSMETIC SURGERY MARKET REVENUE, FOR 30 TO 54, BY REGION , 2021-2031,($MILLION)
    TABLE 21. COSMETIC SURGERY MARKET FOR 30 TO 54 BY COUNTRY, 2021-2031,($MILLION)
    TABLE 22. COSMETIC SURGERY MARKET REVENUE, FOR 55 AND ABOVE, BY REGION , 2021-2031,($MILLION)
    TABLE 23. COSMETIC SURGERY MARKET FOR 55 AND ABOVE BY COUNTRY, 2021-2031,($MILLION)
    TABLE 24. GLOBAL COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 25. COSMETIC SURGERY MARKET REVENUE, FOR AMBULATORY SURGICAL FACILITY, BY REGION , 2021-2031,($MILLION)
    TABLE 26. COSMETIC SURGERY MARKET FOR AMBULATORY SURGICAL FACILITY BY COUNTRY, 2021-2031,($MILLION)
    TABLE 27. COSMETIC SURGERY MARKET REVENUE, FOR HOSPITAL AND CLINIC, BY REGION , 2021-2031,($MILLION)
    TABLE 28. COSMETIC SURGERY MARKET FOR HOSPITAL AND CLINIC BY COUNTRY, 2021-2031,($MILLION)
    TABLE 29. COSMETIC SURGERY MARKET REVENUE, FOR OFFICE AND COSMETIC SURGICAL CENTER, BY REGION , 2021-2031,($MILLION)
    TABLE 30. COSMETIC SURGERY MARKET FOR OFFICE AND COSMETIC SURGICAL CENTER BY COUNTRY, 2021-2031,($MILLION)
    TABLE 31. COSMETIC SURGERY MARKET, BY REGION, 2021-2031,($MILLION)
    TABLE 32. NORTH AMERICA COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 33. NORTH AMERICA COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 34. NORTH AMERICA COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 35. NORTH AMERICA COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 36. NORTH AMERICA COSMETIC SURGERY MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 37. U.S. COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 38. U.S. COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 39. U.S. COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 40. U.S. COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 41. CANADA COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 42. CANADA COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 43. CANADA COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 44. CANADA COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 45. MEXICO COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 46. MEXICO COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 47. MEXICO COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 48. MEXICO COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 49. EUROPE COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 50. EUROPE COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 51. EUROPE COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 52. EUROPE COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 53. EUROPE COSMETIC SURGERY MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 54. GERMANY COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 55. GERMANY COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 56. GERMANY COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 57. GERMANY COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 58. FRANCE COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 59. FRANCE COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 60. FRANCE COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 61. FRANCE COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 62. U.K. COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 63. U.K. COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 64. U.K. COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 65. U.K. COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 66. ITALY COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 67. ITALY COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 68. ITALY COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 69. ITALY COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 70. SPAIN COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 71. SPAIN COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 72. SPAIN COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 73. SPAIN COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 74. REST OF EUROPE COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 75. REST OF EUROPE COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 76. REST OF EUROPE COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 77. REST OF EUROPE COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 78. ASIA-PACIFIC COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 79. ASIA-PACIFIC COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 80. ASIA-PACIFIC COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 81. ASIA-PACIFIC COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 82. ASIA-PACIFIC COSMETIC SURGERY MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 83. CHINA COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 84. CHINA COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 85. CHINA COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 86. CHINA COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 87. JAPAN COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 88. JAPAN COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 89. JAPAN COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 90. JAPAN COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 91. INDIA COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 92. INDIA COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 93. INDIA COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 94. INDIA COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 95. AUSTRALIA COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 96. AUSTRALIA COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 97. AUSTRALIA COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 98. AUSTRALIA COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 99. REST OF ASIA-PACIFIC COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 100. REST OF ASIA-PACIFIC COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 101. REST OF ASIA-PACIFIC COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 102. REST OF ASIA-PACIFIC COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 103. LAMEA COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 104. LAMEA COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 105. LAMEA COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 106. LAMEA COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 107. LAMEA COSMETIC SURGERY MARKET, BY COUNTRY, 2021-2031,($MILLION)
    TABLE 108. BRAZIL COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 109. BRAZIL COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 110. BRAZIL COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 111. BRAZIL COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 112. SAUDI ARABIA COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 113. SAUDI ARABIA COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 114. SAUDI ARABIA COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 115. SAUDI ARABIA COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 116. COLOMBIA COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 117. COLOMBIA COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 118. COLOMBIA COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 119. COLOMBIA COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 120. REST OF LAMEA COSMETIC SURGERY MARKET, BY PROCEDURE, 2021-2031,($MILLION)
    TABLE 121. REST OF LAMEA COSMETIC SURGERY MARKET, BY GENDER, 2021-2031,($MILLION)
    TABLE 122. REST OF LAMEA COSMETIC SURGERY MARKET, BY AGE GROUP, 2021-2031,($MILLION)
    TABLE 123. REST OF LAMEA COSMETIC SURGERY MARKET, BY END USER, 2021-2031,($MILLION)
    TABLE 124.ABBVIE INC: COMPANY SNAPSHOT
    TABLE 125.ABBVIE INC: OPERATING SEGMENTS
    TABLE 126.ABBVIE INC: PRODUCT PORTFOLIO
    TABLE 127.ABBVIE INC: NET SALES,
    TABLE 128.ABBVIE INC: KEY STRATERGIES
    TABLE 129.BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
    TABLE 130.BAUSCH HEALTH COMPANIES INC.: OPERATING SEGMENTS
    TABLE 131.BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
    TABLE 132.BAUSCH HEALTH COMPANIES INC.: NET SALES,
    TABLE 133.BAUSCH HEALTH COMPANIES INC.: KEY STRATERGIES
    TABLE 134.CANDELA SYNERON: COMPANY SNAPSHOT
    TABLE 135.CANDELA SYNERON: OPERATING SEGMENTS
    TABLE 136.CANDELA SYNERON: PRODUCT PORTFOLIO
    TABLE 137.CANDELA SYNERON: NET SALES,
    TABLE 138.CANDELA SYNERON: KEY STRATERGIES
    TABLE 139.CYNOSURE INC: COMPANY SNAPSHOT
    TABLE 140.CYNOSURE INC: OPERATING SEGMENTS
    TABLE 141.CYNOSURE INC: PRODUCT PORTFOLIO
    TABLE 142.CYNOSURE INC: NET SALES,
    TABLE 143.CYNOSURE INC: KEY STRATERGIES
    TABLE 144.GALDERMA SA: COMPANY SNAPSHOT
    TABLE 145.GALDERMA SA: OPERATING SEGMENTS
    TABLE 146.GALDERMA SA: PRODUCT PORTFOLIO
    TABLE 147.GALDERMA SA: NET SALES,
    TABLE 148.GALDERMA SA: KEY STRATERGIES
    TABLE 149.MERZ PHARMA GMBH AND CO. KGAA: COMPANY SNAPSHOT
    TABLE 150.MERZ PHARMA GMBH AND CO. KGAA: OPERATING SEGMENTS
    TABLE 151.MERZ PHARMA GMBH AND CO. KGAA: PRODUCT PORTFOLIO
    TABLE 152.MERZ PHARMA GMBH AND CO. KGAA: NET SALES,
    TABLE 153.MERZ PHARMA GMBH AND CO. KGAA: KEY STRATERGIES
    TABLE 154.SIENTRA INC: COMPANY SNAPSHOT
    TABLE 155.SIENTRA INC: OPERATING SEGMENTS
    TABLE 156.SIENTRA INC: PRODUCT PORTFOLIO
    TABLE 157.SIENTRA INC: NET SALES,
    TABLE 158.SIENTRA INC: KEY STRATERGIES
    TABLE 159.SINCLAIR PHARMACEUTICALS LIMITED: COMPANY SNAPSHOT
    TABLE 160.SINCLAIR PHARMACEUTICALS LIMITED: OPERATING SEGMENTS
    TABLE 161.SINCLAIR PHARMACEUTICALS LIMITED: PRODUCT PORTFOLIO
    TABLE 162.SINCLAIR PHARMACEUTICALS LIMITED: NET SALES,
    TABLE 163.SINCLAIR PHARMACEUTICALS LIMITED: KEY STRATERGIES
    TABLE 164.TEOXANE LABORATORIES: COMPANY SNAPSHOT
    TABLE 165.TEOXANE LABORATORIES: OPERATING SEGMENTS
    TABLE 166.TEOXANE LABORATORIES: PRODUCT PORTFOLIO
    TABLE 167.TEOXANE LABORATORIES: NET SALES,
    TABLE 168.TEOXANE LABORATORIES: KEY STRATERGIES
    TABLE 169.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
    TABLE 170.JOHNSON AND JOHNSON: OPERATING SEGMENTS
    TABLE 171.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
    TABLE 172.JOHNSON AND JOHNSON: NET SALES,
    TABLE 173.JOHNSON AND JOHNSON: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.COSMETIC SURGERY MARKET SEGMENTATION
    FIGURE 2.COSMETIC SURGERY MARKET,2021-2031
    FIGURE 3.COSMETIC SURGERY MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.COSMETIC SURGERY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.COSMETIC SURGERY MARKET,BY PROCEDURE,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BREAST AUGMENTATION COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EYELID SURGERY COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF LIPOSUCTION COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF RHINOPLASTY COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 18.COSMETIC SURGERY MARKET,BY GENDER,2021(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF FEMALE COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MALE COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 21.COSMETIC SURGERY MARKET,BY AGE GROUP,2021(%)
    FIGURE 22.COMPARATIVE SHARE ANALYSIS OF 13 TO 29 COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 23.COMPARATIVE SHARE ANALYSIS OF 30 TO 54 COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 24.COMPARATIVE SHARE ANALYSIS OF 55 AND ABOVE COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 25.COSMETIC SURGERY MARKET,BY END USER,2021(%)
    FIGURE 26.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL FACILITY COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITAL AND CLINIC COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 28.COMPARATIVE SHARE ANALYSIS OF OFFICE AND COSMETIC SURGICAL CENTER COSMETIC SURGERY MARKET,2021-2031(%)
    FIGURE 29.COSMETIC SURGERY MARKET BY REGION,2021
    FIGURE 30.U.S. COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 31.CANADA COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 32.MEXICO COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 33.GERMANY COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 34.FRANCE COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 35.U.K. COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 36.ITALY COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 37.SPAIN COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 38.REST OF EUROPE COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 39.CHINA COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 40.JAPAN COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 41.INDIA COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 42.AUSTRALIA COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 43.REST OF ASIA-PACIFIC COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 44.BRAZIL COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 45.SAUDI ARABIA COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 46.COLOMBIA COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 47.REST OF LAMEA COSMETIC SURGERY MARKET,2021-2031($MILLION)
    FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 52.COMPETITIVE DASHBOARD
    FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 54.ABBVIE INC.: NET SALES ,($MILLION)
    FIGURE 55.BAUSCH HEALTH COMPANIES INC..: NET SALES ,($MILLION)
    FIGURE 56.CANDELA SYNERON.: NET SALES ,($MILLION)
    FIGURE 57.CYNOSURE INC.: NET SALES ,($MILLION)
    FIGURE 58.GALDERMA SA.: NET SALES ,($MILLION)
    FIGURE 59.MERZ PHARMA GMBH AND CO. KGAA.: NET SALES ,($MILLION)
    FIGURE 60.SIENTRA INC.: NET SALES ,($MILLION)
    FIGURE 61.SINCLAIR PHARMACEUTICALS LIMITED.: NET SALES ,($MILLION)
    FIGURE 62.TEOXANE LABORATORIES.: NET SALES ,($MILLION)
    FIGURE 63.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)

 
 

Cosmetic surgery is a voluntary surgical or medical technique, which is performed to enhance the body appearance. It is also a unique discipline of medicine, which focuses on enhancing appearance through surgical and medical techniques. It can be performed on all areas of head, neck, and body. The market for cosmetic surgery is driven by increase in number of cosmetic procedures, increase in number of key players that launch various cosmetic surgery products, increase in number of licensed medical spas, and rise in self- awareness among young population regarding aesthetic appearance. Side-effects associated with cosmetic procedures are anticipated to hinder growth of the market. Development of advanced technology product to boost the demand for cosmetic surgical procedure which giver opportunity to propel the growth of market.

Further, North America is expected to witness highest growth, in terms of revenue, owing to increase in number of licensed medical spas, increase in number of professionals, and adoption of new technologies.

Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in awareness regarding cosmetic surgeries.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of cosmetic surgery market is $67,289.1 million in 2021.

A. The forecast period in the report is from 2022 to 2031

A. The market value of cosmetic surgery Market in 2022 was $74,690.9 million

A. Yes, cosmetic surgery companies are profiled in the report

A. The top companies that hold the market share in cosmetic surgery market are AbbVie Inc., Bausch Health Companies Inc., Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma, Teoxane Laboratories.

A. The key trends in the cosmetic surgery market are increase in prevalence of cosmetic surgical procedure; rise in demand for aesthetic procedure; and rise in technological advancement in healthcare sector

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Cosmetic Surgery Market

Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (May 2023 - May 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (May 2023 - May 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers